| Literature DB >> 24088559 |
Juan F Orueta1, Roberto Nuño-Solinís, Arturo García-Alvarez, Edurne Alonso-Morán.
Abstract
BACKGROUND: Multimorbidity is clearly a major challenge for healthcare systems. However, currently, its magnitude and impact on healthcare expenditures is still not well known. The objective of this paper is to present an overview of the prevalence of multimorbidity by deprivation level in the elderly population of the Basque Country.Entities:
Mesh:
Year: 2013 PMID: 24088559 PMCID: PMC3852493 DOI: 10.1186/1471-2458-13-918
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Mean numbers of chronic diseases and percentage of patients with comorbidity in patient groups according to sex, age and deprivation index quintile
| | |||||||
|---|---|---|---|---|---|---|---|
| Population | 452,698 | 2.65 (2.15) | 2.37 (2.06) | 2.60 (2.10) | 2.72 (2.15) | 2.73 (2.16) | 2.87 (2.23) |
| Men | |||||||
| Age group (years) | |||||||
| 65-69 | 57,267 | 2.03 (1.80) | 1.82 (1.74) | 1.99 (1.74) | 2.11 (1.85) | 2.10 (1.81) | 2.18 (1.88) |
| 70-74 | 41,649 | 2.49 (2.00) | 2.26 (1.92) | 2.46 (1.97) | 2.58 (2.04) | 2.55 (2.02) | 2.59 (2.06) |
| 75-79 | 42,016 | 2.98 (2.22) | 2.74 (2.18) | 2.93 (2.19) | 3.05 (2.22) | 3.06 (2.25) | 3.11 (2.26) |
| 80-84 | 30,110 | 3.34 (2.41) | 3.10 (2.32) | 3.37 (2.39) | 3.45 (2.40) | 3.35 (2.41) | 3.44 (2.50) |
| 85+ | 21,516 | 3.18 (2.57) | 2.92 (2.49) | 3.19 (2.51) | 3.25 (2.60) | 3.29 (2.61) | 3.29 (2.64) |
| All Men | 192,558 | 2.67 (2.19) | 2.42 (2.12) | 2.65 (2.16) | 2.75 (2.21) | 2.74 (2.21) | 2.81 (2.26) |
| Women | |||||||
| Age group (years) | |||||||
| 65-69 | 62,315 | 1.97 (1.73) | 1.67 (1.61) | 1.91 (1.70) | 2.04 (1.75) | 2.05 (1.75) | 2.24 (1.83) |
| 70-74 | 48,447 | 2.39 (1.91) | 2.07 (1.80) | 2.28 (1.84) | 2.45 (1.91) | 2.49 (1.92) | 2.66 (2.03) |
| 75-79 | 55,224 | 2.85 (2.10) | 2.53 (2.01) | 2.73 (2.04) | 2.90 (2.09) | 2.94 (2.12) | 3.13 (2.19) |
| 80-84 | 45,364 | 3.20 (2.25) | 2.89 (2.19) | 3.11 (2.19) | 3.27 (2.22) | 3.29 (2.26) | 3.48 (2.36) |
| 85+ | 48,790 | 2.99 (2.34) | 2.72 (2.26) | 2.96 (2.29) | 3.07 (2.35) | 3.06 (2.34) | 3.22 (2.45) |
| All Women | 260,140 | 2.64 (2.11) | 2.34 (2.03) | 2.56 (2.06) | 2.70 (2.11) | 2.72 (2.12) | 2.91 (2.21) |
Differences statistically significant among Deprivation Index groups (P < 0.0001).
Population with multimorbidity (two or more chronic diseases) by age, sex and deprivation index quintile
| | |||||||
|---|---|---|---|---|---|---|---|
| 54.94% (54.53-55.35) | 49.18% (48.30-50.07) | 54.93% (54.04-55.83) | 56.69% (55.78-57.59) | 56.55% (55.65-57.45) | 58.13% (57.16-59.10) | ||
| 64.69% (64.23-65.15) | 59.38% (58.32-60.44) | 64.41% (63.39-65.44) | 66.80% (65.78-67.82) | 66.10% (65.11-67.09) | 66.74% (65.71-67.76) | ||
| 72.49% (72.07-72.92) | 67.57% (66.53-68.61) | 71.54% (70.57-72.50) | 73.89% (72.95-74.83) | 74.16% (73.26-75.06) | 74.85% (73.92-75.77) | ||
| 76.77% (76.29-77.25) | 73.59% (72.45-74.72) | 77.04% (75.99-78.08) | 78.48% (77.43-79.53) | 77.00% (75.97-78.04) | 77.69% (76.61-78.76) | ||
| 70.74% (70.13-71.35) | 67.13% (65.78-68.49) | 71.60% (70.28-72.91) | 71.34% (69.98-72.70) | 72.18% (70.83-73.52) | 71.84% (70.41-73.27) | ||
| 66.06% (65.85-66.27) | 60.86% (60.37-61.34) | 65.93% (65.46-66.40) | 67.61% (67.14-68.07) | 67.52% (67.06-67.98) | 68.54% (68.06-69.01) | ||
| 53.55% (53.16-53.94) | 46.12% (45.28-46.96) | 51.87% (51.00-52.74) | 55.35% (54.47-56.23) | 55.93% (55.06-56.81) | 59.84% (58.93-60.74) | ||
| 62.92% (62.49-63.35) | 55.55% (54.55-56.54) | 60.71% (59.73-61.68) | 64.34% (63.38-65.31) | 65.68% (64.75-66.61) | 68.17% (67.25-69.10) | ||
| 70.99% (70.61-71.37) | 64.71% (63.80-65.61) | 69.04% (68.17-69.90) | 72.55% (71.70-73.39) | 72.80% (71.99-73.62) | 75.59% (74.79-76.38) | ||
| 76.16% (75.77-76.55) | 70.40% (69.48-71.32) | 75.27% (74.39-76.15) | 78.07% (77.20-78.94) | 77.80% (76.94-78.66) | 79.64% (78.81-80.47) | ||
| 70.66% (70.25-71.06) | 66.11% (65.25-66.96) | 71.02% (70.15-71.90) | 71.95% (71.04-72.87) | 72.00% (71.07-72.93) | 73.66% (72.73-74.60) | ||
| 66.15% (65.97-66.33) | 59.78% (59.37-60.19) | 64.89% (64.48-65.30) | 67.65% (67.25-68.06) | 68.12% (67.72-68.53) | 70.96% (70.57-71.36) | ||
Percentage (95% CI) Differences statistically significant among Deprivation Index groups (P < 0.0001).
Figure 1Percentage of women with multimorbidity (at least 2 and at least 3 chronic conditions) by deprivation index.
Figure 2Percentage of men with multimorbidity (at least 2 and at least 3 chronic conditions) by deprivation index. Note: DI5 corresponds to the most deprived population.
Prevalence of chronic diseases and comorbidities, in the population aged 65 and over in the Basque Country
| Hypertension | 117907 (53%) | 156985 (55%) | 274892 (54%) | 39725 (14%) | 235167 (86%) | 173639 (63%) | 115512 (42%) | 71671 (26%) |
| Diabetes mellitus | 41477 (19%) | 43783 (15%) | 85260 (17%) | 4014 (5%) | 81246 (95%) | 66366 (78%) | 47984 (56%) | 31943 (37%) |
| Degenerative joint disease | 17032 (8%) | 44950 (16%) | 61982 (12%) | 3775 (6%) | 58207 (94%) | 48583 (78%) | 35822 (58%) | 23981 (39%) |
| Treated dyspepsia | 20726 (9%) | 38328 (13%) | 59054 (12%) | 1825 (3%) | 57229 (97%) | 49973 (85%) | 38925 (66%) | 27220 (46%) |
| Anxiety & other neurotic, stress-related & somatoform disorders | 15047 (7%) | 42496 (15%) | 57543 (11%) | 4785 (8%) | 52758 (92%) | 44513 (77%) | 33452 (58%) | 22900 (40%) |
| Atrial fibrillation | 22726 (10%) | 21150 (7%) | 43876 (9%) | 696 (2%) | 43180 (98%) | 39171 (89%) | 32331 (74%) | 24580 (56%) |
| Depression | 9677 (4%) | 33376 (12%) | 43053 (8%) | 1210 (3%) | 41843 (97%) | 37433 (87%) | 29771 (69%) | 21390 (50%) |
| Malignancies | 23850 (11%) | 18110 (6%) | 41960 (8%) | 3288 (8%) | 38672 (92%) | 31849 (76%) | 23344 (56%) | 15662 (37%) |
| Glaucoma | 16609 (7%) | 24265 (8%) | 40874 (8%) | 2436 (6%) | 38438 (94%) | 31913 (78%) | 23233 (57%) | 15429 (38%) |
| Osteoporosis | 2057 (1%) | 36559 (13%) | 38616 (8%) | 3440 (9%) | 35176 (91%) | 28577 (74%) | 20645 (53%) | 13791 (36%) |
| Cerebrovascular disease | 16539 (7%) | 18155 (6%) | 34694 (7%) | 1200 (3%) | 33494 (97%) | 29883 (86%) | 24167 (70%) | 17792 (51%) |
| Prostatic hypertrophy | 33548 (15%) | --- | 33548 (7%) | 2742 (8%) | 30840 (92%) | 25092 (75%) | 18234 (54%) | 12247 (37%) |
| Emphysema, chronic bronchitis, chronic obstructive pulmonary disease | 23032 (10%) | 10359 (4%) | 33391 (7%) | 1576 (5%) | 31815 (95%) | 28036 (84%) | 22632 (68%) | 16888 (51%) |
| Ischemic heart disease | 21019 (9%) | 11185 (4%) | 32204 (6%) | 365 (1%) | 31839 (99%) | 28353 (88%) | 22650 (70%) | 16671 (52%) |
| Chronic heart disease, others | 16661 (7%) | 12997 (5%) | 29658 (6%) | 665 (2%) | 28993 (98%) | 26786 (90%) | 22963 (77%) | 18143 (61%) |
| Hypothyroidism | 4108 (2%) | 23897 (8%) | 28005 (5%) | 2227 (8%) | 25778 (92%) | 20904 (75%) | 15138 (54%) | 10139 (36%) |
| Low back pain | 8327 (4%) | 18224 (6%) | 26551 (5%) | 1457 (5%) | 25094 (95%) | 21463 (81%) | 16312 (61%) | 11176 (42%) |
| Dementia | 7780 (3%) | 17134 (6%) | 24914 (5%) | 1518 (6%) | 23396 (94%) | 20154 (81%) | 15764 (63%) | 11516 (46%) |
| Chronic kidney disease | 10430 (5%) | 10367 (4%) | 20797 (4%) | 191 (1%) | 20606 (99%) | 19245 (93%) | 16613 (80%) | 13260 (64%) |
| Heart failure | 8434 (4%) | 10289 (4%) | 18723 (4%) | 67 (0%) | 18656 (100%) | 18201 (97%) | 16966 (91%) | 14796 (79%) |
| Deafness, hearing loss | 7871 (4%) | 10115 (4%) | 17986 (4%) | 2211 (12%) | 15775 (88%) | 13006 (72%) | 9779 (54%) | 6712 (37%) |
| Asthma (currently treated) | 6129 (3%) | 11241 (4%) | 17370 (3%) | 3406 (20%) | 13964 (80%) | 11729 (68%) | 9204 (53%) | 6615 (38%) |
| Blindness & low vision | 7150 (3%) | 10035 (3%) | 17185 (3%) | 1239 (7%) | 15946 (93%) | 13745 (80%) | 10681 (62%) | 7632 (44%) |
| Peripheral neuropathy, neuritis | 5030 (2%) | 9673 (3%) | 14703 (3%) | 791 (5%) | 13912 (95%) | 11931 (81%) | 9275 (63%) | 6630 (45%) |
| Diverticular disease of intestine | 5162 (2%) | 8534 (3%) | 13696 (3%) | 442 (3%) | 13254 (97%) | 12001 (88%) | 9835 (72%) | 7451 (54%) |
| Gout | 10332 (5%) | 2488 (1%) | 12820 (3%) | 564 (4%) | 12256 (96%) | 10542 (82%) | 8125 (63%) | 5876 (46%) |
| Rheumatoid arthritis and autoimmune and connective tissue diseases | 3949 (2%) | 7606 (3%) | 11555 (2%) | 629 (5%) | 10926 (95%) | 9454 (82%) | 7347 (64%) | 5226 (45%) |
| Parkinson’s disease | 3941 (2%) | 5204 (2%) | 9145 (2%) | 461 (5%) | 8684 (95%) | 7584 (83%) | 5939 (65%) | 4270 (47%) |
| Chromosomal anomalies or inherited metabolic disorders | 4311 (2%) | 3593 (1%) | 7904 (2%) | 595 (8%) | 7309 (92%) | 6027 (76%) | 4440 (56%) | 3059 (39%) |
| Chronic liver or pancreatic disease | 4101 (2%) | 3000 (1%) | 7101 (1%) | 227 (3%) | 6874 (97%) | 6243 (88%) | 5201 (73%) | 4092 (58%) |
| Peripheral vascular disease | 4732 (2%) | 1269 (0%) | 6001 (1%) | 104 (2%) | 5897 (98%) | 5525 (92%) | 4771 (80%) | 3865 (64%) |
| Treated constipation | 2100 (1%) | 3816 (1%) | 5916 (1%) | 108 (2%) | 5808 (98%) | 5362 (91%) | 4560 (77%) | 3536 (60%) |
| Paralysis or muscular dystrophy | 2701 (1%) | 2684 (1%) | 5385 (1%) | 183 (3%) | 5202 (97%) | 4841 (90%) | 4220 (78%) | 3418 (63%) |
| Schizophrenia, affective psychosis or bipolar disorder | 1487 (1%) | 2500 (1%) | 3987 (1%) | 304 (8%) | 3683 (92%) | 3163 (79%) | 2530 (63%) | 1905 (48%) |
| Bronchiectasis | 1582 (1%) | 1897 (1%) | 3479 (1%) | 5 (0%) | 3474 (100%) | 3265 (94%) | 2868 (82%) | 2280 (66%) |
| Disorders of the immune system | 1327 (1%) | 1899 (1%) | 3226 (1%) | 176 (5%) | 3050 (95%) | 2710 (84%) | 2202 (68%) | 1712 (53%) |
| Irritable bowel syndrome | 834 (0%) | 2200 (1%) | 3034 (1%) | 144 (5%) | 2890 (95%) | 2562 (84%) | 2044 (67%) | 1464 (48%) |
| Epilepsy (currently treated) | 1395 (1%) | 1372 (0%) | 2767 (1%) | 228 (8%) | 2539 (92%) | 2153 (78%) | 1741 (63%) | 1288 (47%) |
| Psoriasis or eczema | 1533 (1%) | 1186 (0%) | 2719 (1%) | 107 (4%) | 2612 (96%) | 2272 (84%) | 1793 (66%) | 1254 (46%) |
| Viral hepatitis | 1110 (0%) | 1456 (1%) | 2566 (1%) | 156 (6%) | 2410 (94%) | 2088 (81%) | 1679 (65%) | 1266 (49%) |
| Hematologic chronic disorders | 1048 (0%) | 1124 (0%) | 2172 (0%) | 124 (6%) | 2048 (94%) | 1856 (85%) | 1626 (75%) | 1321 (61%) |
| Alcohol problems | 1764 (1%) | 372 (0%) | 2136 (0%) | 109 (5%) | 2027 (95%) | 1796 (84%) | 1472 (69%) | 1141 (53%) |
| Inflammatory bowel disease | 974 (0%) | 1096 (0%) | 2070 (0%) | 124 (6%) | 1946 (94%) | 1673 (81%) | 1303 (63%) | 941 (45%) |
| Chronic sinusitis | 531 (0%) | 901 (0%) | 1432 (0%) | 126 (9%) | 1306 (91%) | 1105 (77%) | 851 (59%) | 600 (42%) |
| Intellectual disability | 742 (0%) | 490 (0%) | 1232 (0%) | 692 (56%) | 540 (44%) | 258 (21%) | 179 (15%) | 117 (9%) |
| Migraine | 117 (0%) | 652 (0%) | 769 (0%) | 72 (9%) | 697 (91%) | 569 (74%) | 406 (53%) | 259 (34%) |
| Transplant status | 474 (0%) | 275 (0%) | 749 (0%) | 14 (2%) | 735 (98%) | 691 (92%) | 605 (81%) | 477 (64%) |
Percentage of population with mental health problems and physical multimorbidity
| 22.50% | 74.97% | (74.70-75.23) | 58.14% | (57.98-58.30) | |
| 14.47% | 79.16% | (78.68-79.63) | 61.28% | (61.04-61.51) | |
| 28.45% | 73.39% | (73.07-73.71) | 55.36% | (55.13-55.59) | |
| 18.16% | 63.27% | (62.63-63.92) | 46.59% | (46.28-46.90) | |
| 19.48% | 72.16% | (71.49-72.82) | 56.71% | (56.35-57,07) | |
| 22.78% | 78.87% | (78.33-79.41) | 64.69% | (64.35-65.03) | |
| 26.95% | 81.53% | (80.99-82.06) | 69.08% | (68.69-69.46) | |
| 28.60% | 79.12% | (78.56-79.68) | 60.90% | (60.48-61.33) | |
| 21.16% | 71.67% | (71.05-72.30) | 51.67% | (51.31-52.03) | |
| 22.13% | 73.29% | (72.69-73.90) | 57.44% | (57.08-57.80) | |
| 22.69% | 75.89% | (75.30-76.48) | 59.92% | (59.55-60.29) | |
| 22.44% | 75.75% | (75.17-76.33) | 60.29% | (59.93-60.65) | |
| 24.25% | 78.09% | (77.53-78.65) | 62.04% | (61.67-62.41) | |
CI Confidence Interval (95%).
Physical multimorbidity was considered the concurrence of two or more chronic non-mental diseases in the same person.
They were considered as Mental health problems: Depression; Anxiety & other neurotic, stress related & somatoform disorders; Alcohol problems; Dementia; Schizophrenia, affective psychosis or bipolar disorder; Intellectual disability.